AbbVie announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults...
The 13th meeting of the Russian-Arab Business Council session was held on 25-26 January.
Russia's pharmaceutical industry has managed not only to adapt to the...
Argentina has displayed an interest in the nasal form of Russia's Sputnik V coronavirus vaccine and other Russian developments for treating and preventing COVID-19,...
The Gamaleya Institute is ready to file papers to Russian Health Ministry to obtain permission for research of new platforms for COVID vaccines, Institute...
Experts from the Russian sanitary watchdog’s Vector center have been briefed about a new coronavirus discovered in South Africa, named NeoCov, the center said...